Burna AI reads clinical documentation, finds each adverse event, proposes its CTCAE grade, scores attribution to every drug in the regimen with the WHO-UMC and Kramer methods and codes it to MedDRA, with every grade traced to the line in the medical record that produced it, for a clinician to review and sign. The company describes itself in one line: The AI platform for accelerated clinical research, from first-in-human trials through postmarket surveillance. Burna AI performs automated adverse event grading and attribution in real time, providing clear rationale and audit-ready evidence, including generation of IRB, sponsor and FDA reports. Burna AI delivers CTCAE v5 and v6 grades and MedDRA LLT codes on every encounter; enabling standardization, cross-site consistency and accuracy of clinical research data. AI suggests, clinicians decide. Human-in-the-loop, always.